nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—NOS3—obesity	0.461	0.783	CbGaD
Tetrahydrobiopterin—PTGS2—obesity	0.128	0.217	CbGaD
Tetrahydrobiopterin—TH—area postrema—obesity	0.033	0.271	CbGeAlD
Tetrahydrobiopterin—NOS3—tunica intima—obesity	0.0114	0.0934	CbGeAlD
Tetrahydrobiopterin—TH—sympathetic nervous system—obesity	0.0114	0.0932	CbGeAlD
Tetrahydrobiopterin—TH—vagus nerve—obesity	0.011	0.0903	CbGeAlD
Tetrahydrobiopterin—TH—autonomic nervous system—obesity	0.00763	0.0626	CbGeAlD
Tetrahydrobiopterin—TPH1—hindbrain—obesity	0.00676	0.0555	CbGeAlD
Tetrahydrobiopterin—PAH—gall bladder—obesity	0.00523	0.0429	CbGeAlD
Tetrahydrobiopterin—PTGS2—ovarian follicle—obesity	0.00424	0.0348	CbGeAlD
Tetrahydrobiopterin—TH—hindbrain—obesity	0.00322	0.0264	CbGeAlD
Tetrahydrobiopterin—TPH1—digestive system—obesity	0.00262	0.0215	CbGeAlD
Tetrahydrobiopterin—TPH1—endocrine gland—obesity	0.00217	0.0178	CbGeAlD
Tetrahydrobiopterin—Abdominal pain upper—Phendimetrazine—obesity	0.00201	0.016	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Diethylpropion—obesity	0.00195	0.0155	CcSEcCtD
Tetrahydrobiopterin—Irritability—Phenylpropanolamine—obesity	0.0018	0.0143	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Diethylpropion—obesity	0.00179	0.0142	CcSEcCtD
Tetrahydrobiopterin—NOS3—respiratory system—obesity	0.00177	0.0145	CbGeAlD
Tetrahydrobiopterin—PAH—endocrine gland—obesity	0.0017	0.014	CbGeAlD
Tetrahydrobiopterin—TH—adrenal cortex—obesity	0.00165	0.0135	CbGeAlD
Tetrahydrobiopterin—PAH—liver—obesity	0.00153	0.0126	CbGeAlD
Tetrahydrobiopterin—TH—cardiovascular system—obesity	0.0015	0.0123	CbGeAlD
Tetrahydrobiopterin—Pharyngolaryngeal pain—Bupropion—obesity	0.00142	0.0113	CcSEcCtD
Tetrahydrobiopterin—Laryngeal pain—Bupropion—obesity	0.0014	0.0112	CcSEcCtD
Tetrahydrobiopterin—Agitation—Methamphetamine—obesity	0.00139	0.011	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Phentermine—obesity	0.00137	0.0109	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Phentermine—obesity	0.00136	0.0108	CcSEcCtD
Tetrahydrobiopterin—NOS3—cardiovascular system—obesity	0.00135	0.0111	CbGeAlD
Tetrahydrobiopterin—Agitation—Benzphetamine—obesity	0.00134	0.0106	CcSEcCtD
Tetrahydrobiopterin—TH—pituitary gland—obesity	0.00133	0.0109	CbGeAlD
Tetrahydrobiopterin—Cardiovascular disorder—Orlistat—obesity	0.00129	0.0103	CcSEcCtD
Tetrahydrobiopterin—Contusion—Sibutramine—obesity	0.00126	0.01	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Sibutramine—obesity	0.00125	0.00993	CcSEcCtD
Tetrahydrobiopterin—TH—digestive system—obesity	0.00125	0.0102	CbGeAlD
Tetrahydrobiopterin—Agitation—Phendimetrazine—obesity	0.00122	0.00969	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Cimetidine—obesity	0.00121	0.00958	CcSEcCtD
Tetrahydrobiopterin—TH—adrenal gland—obesity	0.00119	0.00976	CbGeAlD
Tetrahydrobiopterin—Rhinorrhoea—Bupropion—obesity	0.00118	0.00939	CcSEcCtD
Tetrahydrobiopterin—NOS3—digestive system—obesity	0.00112	0.00922	CbGeAlD
Tetrahydrobiopterin—Contusion—Bupropion—obesity	0.0011	0.00872	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Bupropion—obesity	0.00109	0.00865	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Methamphetamine—obesity	0.00109	0.00862	CcSEcCtD
Tetrahydrobiopterin—NOS3—adrenal gland—obesity	0.00107	0.00879	CbGeAlD
Tetrahydrobiopterin—Gastrointestinal disorder—Methamphetamine—obesity	0.00106	0.00846	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Benzphetamine—obesity	0.00105	0.00831	CcSEcCtD
Tetrahydrobiopterin—Agitation—Phenylpropanolamine—obesity	0.00104	0.00828	CcSEcCtD
Tetrahydrobiopterin—TH—endocrine gland—obesity	0.00103	0.00847	CbGeAlD
Tetrahydrobiopterin—Gastrointestinal disorder—Benzphetamine—obesity	0.00103	0.00815	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Orlistat—obesity	0.00103	0.00815	CcSEcCtD
Tetrahydrobiopterin—Agitation—Phentermine—obesity	0.000998	0.00792	CcSEcCtD
Tetrahydrobiopterin—Hyperkinesia—Sibutramine—obesity	0.000958	0.00761	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Orlistat—obesity	0.000938	0.00745	CcSEcCtD
Tetrahydrobiopterin—NOS3—endocrine gland—obesity	0.000929	0.00762	CbGeAlD
Tetrahydrobiopterin—Hypersensitivity—Methamphetamine—obesity	0.000909	0.00722	CcSEcCtD
Tetrahydrobiopterin—PTGS2—gall bladder—obesity	0.000905	0.00743	CbGeAlD
Tetrahydrobiopterin—Hypersensitivity—Benzphetamine—obesity	0.000876	0.00696	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Sibutramine—obesity	0.000875	0.00695	CcSEcCtD
Tetrahydrobiopterin—Agitation—Diethylpropion—obesity	0.000868	0.00689	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Bupropion—obesity	0.000866	0.00688	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Phendimetrazine—obesity	0.000857	0.0068	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Methamphetamine—obesity	0.000844	0.0067	CcSEcCtD
Tetrahydrobiopterin—NOS3—liver—obesity	0.000837	0.00687	CbGeAlD
Tetrahydrobiopterin—Hyperkinesia—Bupropion—obesity	0.000835	0.00663	CcSEcCtD
Tetrahydrobiopterin—Agitation—Cimetidine—obesity	0.000826	0.00656	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Diethylpropion—obesity	0.000818	0.0065	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Methamphetamine—obesity	0.000816	0.00648	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Benzphetamine—obesity	0.000814	0.00646	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Sibutramine—obesity	0.000797	0.00633	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Bupropion—obesity	0.000792	0.00629	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Benzphetamine—obesity	0.000786	0.00625	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Phentermine—obesity	0.00078	0.00619	CcSEcCtD
Tetrahydrobiopterin—Headache—Methamphetamine—obesity	0.000773	0.00614	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Cimetidine—obesity	0.000765	0.00608	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Phentermine—obesity	0.000765	0.00607	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Bupropion—obesity	0.000763	0.00606	CcSEcCtD
Tetrahydrobiopterin—Rhinorrhoea—Topiramate—obesity	0.000753	0.00598	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Orlistat—obesity	0.000752	0.00598	CcSEcCtD
Tetrahydrobiopterin—Headache—Benzphetamine—obesity	0.000745	0.00592	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Phendimetrazine—obesity	0.000742	0.00589	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Cimetidine—obesity	0.000733	0.00582	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Orlistat—obesity	0.000729	0.00579	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Phendimetrazine—obesity	0.000717	0.00569	CcSEcCtD
Tetrahydrobiopterin—Nausea—Benzphetamine—obesity	0.000706	0.00561	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Sibutramine—obesity	0.000706	0.0056	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Diethylpropion—obesity	0.000702	0.00558	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Phentermine—obesity	0.0007	0.00556	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Bupropion—obesity	0.000695	0.00552	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Topiramate—obesity	0.000694	0.00551	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Phenylpropanolamine—obesity	0.000682	0.00542	CcSEcCtD
Tetrahydrobiopterin—Headache—Phendimetrazine—obesity	0.000679	0.00539	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Diethylpropion—obesity	0.000679	0.00539	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Cimetidine—obesity	0.000668	0.00531	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Diethylpropion—obesity	0.000665	0.00528	CcSEcCtD
Tetrahydrobiopterin—Irritability—Bupropion—obesity	0.000663	0.00527	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Orlistat—obesity	0.000662	0.00526	CcSEcCtD
Tetrahydrobiopterin—Nausea—Phendimetrazine—obesity	0.000644	0.00511	CcSEcCtD
Tetrahydrobiopterin—Infestation—Orlistat—obesity	0.000635	0.00504	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Orlistat—obesity	0.000635	0.00504	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Bupropion—obesity	0.000635	0.00504	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Bupropion—obesity	0.000622	0.00494	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Orlistat—obesity	0.000617	0.0049	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Bupropion—obesity	0.000615	0.00489	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Phenylpropanolamine—obesity	0.000612	0.00486	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Phentermine—obesity	0.000606	0.00481	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Sibutramine—obesity	0.000606	0.00481	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Sibutramine—obesity	0.000602	0.00478	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Sibutramine—obesity	0.000597	0.00474	CcSEcCtD
Tetrahydrobiopterin—PTGS2—islet of Langerhans—obesity	0.000593	0.00487	CbGeAlD
Tetrahydrobiopterin—Vomiting—Phenylpropanolamine—obesity	0.000589	0.00468	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Phentermine—obesity	0.000586	0.00465	CcSEcCtD
Tetrahydrobiopterin—Rash—Phenylpropanolamine—obesity	0.000584	0.00464	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Phenylpropanolamine—obesity	0.000583	0.00463	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Cimetidine—obesity	0.00058	0.0046	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Orlistat—obesity	0.000566	0.00449	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Phentermine—obesity	0.000563	0.00447	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Orlistat—obesity	0.000561	0.00446	CcSEcCtD
Tetrahydrobiopterin—PTGS2—respiratory system—obesity	0.00056	0.0046	CbGeAlD
Tetrahydrobiopterin—Rash—Phentermine—obesity	0.000559	0.00444	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Bupropion—obesity	0.000558	0.00443	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Phentermine—obesity	0.000558	0.00443	CcSEcCtD
Tetrahydrobiopterin—Headache—Phentermine—obesity	0.000555	0.00441	CcSEcCtD
Tetrahydrobiopterin—Urine output increased—Topiramate—obesity	0.000552	0.00438	CcSEcCtD
Tetrahydrobiopterin—Nausea—Phenylpropanolamine—obesity	0.00055	0.00437	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Sibutramine—obesity	0.000547	0.00435	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Sibutramine—obesity	0.000543	0.00432	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Cimetidine—obesity	0.00054	0.00429	CcSEcCtD
Tetrahydrobiopterin—Infestation—Bupropion—obesity	0.000536	0.00425	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Bupropion—obesity	0.000536	0.00425	CcSEcCtD
Tetrahydrobiopterin—Hyperkinesia—Topiramate—obesity	0.000532	0.00423	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Bupropion—obesity	0.000528	0.00419	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Diethylpropion—obesity	0.000527	0.00419	CcSEcCtD
Tetrahydrobiopterin—Nausea—Phentermine—obesity	0.000526	0.00418	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Bupropion—obesity	0.000525	0.00417	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Bupropion—obesity	0.000521	0.00413	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Orlistat—obesity	0.000514	0.00408	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Diethylpropion—obesity	0.00051	0.00405	CcSEcCtD
Tetrahydrobiopterin—Polyuria—Topiramate—obesity	0.000504	0.00401	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Cimetidine—obesity	0.000502	0.00399	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Orlistat—obesity	0.000496	0.00394	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Diethylpropion—obesity	0.00049	0.00389	CcSEcCtD
Tetrahydrobiopterin—Nasal congestion—Topiramate—obesity	0.000486	0.00386	CcSEcCtD
Tetrahydrobiopterin—Rash—Diethylpropion—obesity	0.000486	0.00386	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Diethylpropion—obesity	0.000486	0.00386	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Cimetidine—obesity	0.000485	0.00385	CcSEcCtD
Tetrahydrobiopterin—Headache—Diethylpropion—obesity	0.000483	0.00383	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Sibutramine—obesity	0.00048	0.00381	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Bupropion—obesity	0.000477	0.00379	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Bupropion—obesity	0.000474	0.00376	CcSEcCtD
Tetrahydrobiopterin—PTGS2—adrenal cortex—obesity	0.00047	0.00386	CbGeAlD
Tetrahydrobiopterin—Vomiting—Cimetidine—obesity	0.000466	0.0037	CcSEcCtD
Tetrahydrobiopterin—Rash—Cimetidine—obesity	0.000462	0.00367	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Cimetidine—obesity	0.000462	0.00367	CcSEcCtD
Tetrahydrobiopterin—Headache—Cimetidine—obesity	0.000459	0.00365	CcSEcCtD
Tetrahydrobiopterin—Nausea—Diethylpropion—obesity	0.000458	0.00364	CcSEcCtD
Tetrahydrobiopterin—Agitation—Sibutramine—obesity	0.000441	0.0035	CcSEcCtD
Tetrahydrobiopterin—Nausea—Cimetidine—obesity	0.000436	0.00346	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Bupropion—obesity	0.000433	0.00344	CcSEcCtD
Tetrahydrobiopterin—Cough—Orlistat—obesity	0.000433	0.00344	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Orlistat—obesity	0.00043	0.00341	CcSEcCtD
Tetrahydrobiopterin—PTGS2—cardiovascular system—obesity	0.000429	0.00352	CbGeAlD
Tetrahydrobiopterin—Irritability—Topiramate—obesity	0.000423	0.00336	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000419	0.00333	CcSEcCtD
Tetrahydrobiopterin—Cough—Sibutramine—obesity	0.000419	0.00333	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Bupropion—obesity	0.000419	0.00332	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Sibutramine—obesity	0.000416	0.0033	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Sibutramine—obesity	0.000409	0.00325	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Orlistat—obesity	0.000405	0.00322	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Topiramate—obesity	0.000404	0.00321	CcSEcCtD
Tetrahydrobiopterin—Infection—Orlistat—obesity	0.000402	0.00319	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Orlistat—obesity	0.000397	0.00315	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Topiramate—obesity	0.000396	0.00314	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Orlistat—obesity	0.000393	0.00312	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Topiramate—obesity	0.000392	0.00311	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Sibutramine—obesity	0.000392	0.00311	CcSEcCtD
Tetrahydrobiopterin—Infection—Sibutramine—obesity	0.000389	0.00309	CcSEcCtD
Tetrahydrobiopterin—Agitation—Bupropion—obesity	0.000385	0.00305	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Sibutramine—obesity	0.000381	0.00302	CcSEcCtD
Tetrahydrobiopterin—PTGS2—pituitary gland—obesity	0.00038	0.00312	CbGeAlD
Tetrahydrobiopterin—PTGS2—adipose tissue—obesity	0.000378	0.0031	CbGeAlD
Tetrahydrobiopterin—Musculoskeletal discomfort—Orlistat—obesity	0.000369	0.00293	CcSEcCtD
Tetrahydrobiopterin—Cough—Bupropion—obesity	0.000365	0.0029	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Bupropion—obesity	0.000363	0.00288	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Topiramate—obesity	0.000358	0.00284	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Sibutramine—obesity	0.000357	0.00284	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Orlistat—obesity	0.000356	0.00283	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Bupropion—obesity	0.000356	0.00283	CcSEcCtD
Tetrahydrobiopterin—PTGS2—digestive system—obesity	0.000356	0.00292	CbGeAlD
Tetrahydrobiopterin—Upper respiratory tract infection—Topiramate—obesity	0.000356	0.00282	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000354	0.00281	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Orlistat—obesity	0.00035	0.00278	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Sibutramine—obesity	0.000345	0.00274	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Bupropion—obesity	0.000342	0.00271	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Topiramate—obesity	0.000341	0.00271	CcSEcCtD
Tetrahydrobiopterin—Infestation—Topiramate—obesity	0.000341	0.00271	CcSEcCtD
Tetrahydrobiopterin—Infection—Bupropion—obesity	0.000339	0.0027	CcSEcCtD
Tetrahydrobiopterin—PTGS2—adrenal gland—obesity	0.000339	0.00278	CbGeAlD
Tetrahydrobiopterin—Gastrointestinal disorder—Sibutramine—obesity	0.000338	0.00269	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Bupropion—obesity	0.000335	0.00266	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Bupropion—obesity	0.000332	0.00264	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Topiramate—obesity	0.000332	0.00263	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Orlistat—obesity	0.000331	0.00263	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Sibutramine—obesity	0.00032	0.00254	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Orlistat—obesity	0.00032	0.00254	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Orlistat—obesity	0.00032	0.00254	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Bupropion—obesity	0.000311	0.00247	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Sibutramine—obesity	0.00031	0.00246	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Sibutramine—obesity	0.00031	0.00246	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Topiramate—obesity	0.000304	0.00241	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Topiramate—obesity	0.000302	0.0024	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Bupropion—obesity	0.000301	0.00239	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Orlistat—obesity	0.000298	0.00237	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Bupropion—obesity	0.000295	0.00234	CcSEcCtD
Tetrahydrobiopterin—PTGS2—endocrine gland—obesity	0.000294	0.00241	CbGeAlD
Tetrahydrobiopterin—Hypersensitivity—Sibutramine—obesity	0.000289	0.00229	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Bupropion—obesity	0.000279	0.00222	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Orlistat—obesity	0.000277	0.0022	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Topiramate—obesity	0.000276	0.00219	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Bupropion—obesity	0.00027	0.00214	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Bupropion—obesity	0.00027	0.00214	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Sibutramine—obesity	0.000268	0.00213	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Orlistat—obesity	0.000268	0.00213	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Topiramate—obesity	0.000267	0.00212	CcSEcCtD
Tetrahydrobiopterin—PTGS2—liver—obesity	0.000265	0.00218	CbGeAlD
Tetrahydrobiopterin—Dizziness—Sibutramine—obesity	0.000259	0.00206	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Orlistat—obesity	0.000257	0.00204	CcSEcCtD
Tetrahydrobiopterin—Rash—Orlistat—obesity	0.000255	0.00203	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Orlistat—obesity	0.000255	0.00203	CcSEcCtD
Tetrahydrobiopterin—Headache—Orlistat—obesity	0.000254	0.00201	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Bupropion—obesity	0.000252	0.002	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Sibutramine—obesity	0.000249	0.00198	CcSEcCtD
Tetrahydrobiopterin—Rash—Sibutramine—obesity	0.000247	0.00196	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Sibutramine—obesity	0.000247	0.00196	CcSEcCtD
Tetrahydrobiopterin—Headache—Sibutramine—obesity	0.000245	0.00195	CcSEcCtD
Tetrahydrobiopterin—Agitation—Topiramate—obesity	0.000245	0.00195	CcSEcCtD
Tetrahydrobiopterin—Nausea—Orlistat—obesity	0.000241	0.00191	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Bupropion—obesity	0.000234	0.00186	CcSEcCtD
Tetrahydrobiopterin—Nausea—Sibutramine—obesity	0.000233	0.00185	CcSEcCtD
Tetrahydrobiopterin—Cough—Topiramate—obesity	0.000233	0.00185	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Topiramate—obesity	0.000231	0.00184	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Topiramate—obesity	0.000227	0.0018	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Bupropion—obesity	0.000226	0.00179	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000225	0.00179	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Bupropion—obesity	0.000217	0.00173	CcSEcCtD
Tetrahydrobiopterin—Infection—Topiramate—obesity	0.000216	0.00172	CcSEcCtD
Tetrahydrobiopterin—Rash—Bupropion—obesity	0.000215	0.00171	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Bupropion—obesity	0.000215	0.00171	CcSEcCtD
Tetrahydrobiopterin—Headache—Bupropion—obesity	0.000214	0.0017	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Topiramate—obesity	0.000213	0.0017	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Topiramate—obesity	0.000211	0.00168	CcSEcCtD
Tetrahydrobiopterin—Nausea—Bupropion—obesity	0.000203	0.00161	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Topiramate—obesity	0.000198	0.00157	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Topiramate—obesity	0.000192	0.00152	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Topiramate—obesity	0.000188	0.00149	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Topiramate—obesity	0.000178	0.00141	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Topiramate—obesity	0.000172	0.00137	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Topiramate—obesity	0.000172	0.00137	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Topiramate—obesity	0.00016	0.00127	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Topiramate—obesity	0.000149	0.00118	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Topiramate—obesity	0.000144	0.00114	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Topiramate—obesity	0.000138	0.0011	CcSEcCtD
Tetrahydrobiopterin—Rash—Topiramate—obesity	0.000137	0.00109	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Topiramate—obesity	0.000137	0.00109	CcSEcCtD
Tetrahydrobiopterin—Headache—Topiramate—obesity	0.000136	0.00108	CcSEcCtD
Tetrahydrobiopterin—Nausea—Topiramate—obesity	0.000129	0.00103	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Metabolism—UCP2—obesity	1.49e-05	9.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ECHS1—obesity	1.49e-05	9.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—UCP3—obesity	1.49e-05	9.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HSD11B1—obesity	1.49e-05	9.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CAV1—obesity	1.49e-05	9.08e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PLG—obesity	1.49e-05	9.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APOA1—obesity	1.48e-05	9.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—STAT3—obesity	1.47e-05	9e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ADH1B—obesity	1.46e-05	8.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GPX1—obesity	1.46e-05	8.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO3—obesity	1.45e-05	8.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ADRB2—obesity	1.45e-05	8.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOB—obesity	1.44e-05	8.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ACSL1—obesity	1.44e-05	8.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPAM—obesity	1.44e-05	8.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARGC1B—obesity	1.44e-05	8.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CD—obesity	1.44e-05	8.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CD36—obesity	1.43e-05	8.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SOCS1—obesity	1.43e-05	8.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ALB—obesity	1.42e-05	8.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SOCS3—obesity	1.41e-05	8.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FADS1—obesity	1.4e-05	8.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HADH—obesity	1.4e-05	8.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PCK1—obesity	1.4e-05	8.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BAD—obesity	1.4e-05	8.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GNB3—obesity	1.38e-05	8.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—LPL—obesity	1.38e-05	8.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—obesity	1.37e-05	8.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	1.37e-05	8.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—obesity	1.37e-05	8.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TGFB1—obesity	1.37e-05	8.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ACP5—obesity	1.36e-05	8.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3R1—obesity	1.36e-05	8.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—NOS3—obesity	1.36e-05	8.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF2—obesity	1.35e-05	8.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—MTHFR—obesity	1.35e-05	8.25e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RBP4—obesity	1.35e-05	8.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—obesity	1.34e-05	8.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GNAS—obesity	1.34e-05	8.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IRS1—obesity	1.34e-05	8.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CA—obesity	1.33e-05	8.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—G6PD—obesity	1.33e-05	8.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARA—obesity	1.33e-05	8.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOB—obesity	1.31e-05	8.02e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HK1—obesity	1.31e-05	8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SREBF2—obesity	1.31e-05	8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CD36—obesity	1.31e-05	7.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—obesity	1.31e-05	7.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AGT—obesity	1.28e-05	7.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL5—obesity	1.28e-05	7.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—INS—obesity	1.28e-05	7.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—obesity	1.28e-05	7.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKAR2B—obesity	1.28e-05	7.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CST3—obesity	1.28e-05	7.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—DCN—obesity	1.27e-05	7.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LPA—obesity	1.27e-05	7.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOE—obesity	1.26e-05	7.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CB—obesity	1.25e-05	7.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LPL—obesity	1.25e-05	7.66e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CAV1—obesity	1.25e-05	7.61e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FOXO1—obesity	1.25e-05	7.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RPS6KB1—obesity	1.24e-05	7.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—obesity	1.24e-05	7.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—APOA1—obesity	1.24e-05	7.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT2—obesity	1.24e-05	7.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LPIN1—obesity	1.24e-05	7.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NCF2—obesity	1.23e-05	7.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARA—obesity	1.22e-05	7.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOA5—obesity	1.21e-05	7.41e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NAMPT—obesity	1.21e-05	7.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GCK—obesity	1.2e-05	7.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOC3—obesity	1.19e-05	7.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IAPP—obesity	1.19e-05	7.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CD—obesity	1.19e-05	7.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—AGT—obesity	1.18e-05	7.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SERPINE1—obesity	1.18e-05	7.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	1.17e-05	7.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—obesity	1.16e-05	7.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CLOCK—obesity	1.16e-05	7.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC22A1—obesity	1.16e-05	7.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PRKCD—obesity	1.16e-05	7.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOE—obesity	1.16e-05	7.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TYK2—obesity	1.15e-05	7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SDC1—obesity	1.15e-05	6.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CAV1—obesity	1.14e-05	6.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—APOA1—obesity	1.14e-05	6.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RHOA—obesity	1.14e-05	6.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CG—obesity	1.14e-05	6.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HTR2A—obesity	1.13e-05	6.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—C3—obesity	1.13e-05	6.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SULT2A1—obesity	1.13e-05	6.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GLP1R—obesity	1.13e-05	6.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKR1C3—obesity	1.13e-05	6.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3R1—obesity	1.13e-05	6.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—DPYD—obesity	1.11e-05	6.78e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PPARG—obesity	1.1e-05	6.69e-05	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AKT1—obesity	1.09e-05	6.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—POMC—obesity	1.08e-05	6.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IRS2—obesity	1.07e-05	6.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—INS—obesity	1.07e-05	6.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AGT—obesity	1.07e-05	6.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PRKAR2B—obesity	1.07e-05	6.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—AKT1—obesity	1.07e-05	6.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—DCN—obesity	1.06e-05	6.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOE—obesity	1.05e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—LEP—obesity	1.05e-05	6.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GOT2—obesity	1.05e-05	6.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.04e-05	6.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CAV1—obesity	1.04e-05	6.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APOA1—obesity	1.04e-05	6.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTOR—obesity	1.04e-05	6.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CB—obesity	1.04e-05	6.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CPT1A—obesity	1.03e-05	6.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—IL6—obesity	1.03e-05	6.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—obesity	1.03e-05	6.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FASN—obesity	1.03e-05	6.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PARP1—obesity	1.02e-05	6.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NAMPT—obesity	1.01e-05	6.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—obesity	1.01e-05	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LIPC—obesity	1.01e-05	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GCK—obesity	1.01e-05	6.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ESR1—obesity	1e-05	6.13e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOC3—obesity	9.99e-06	6.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CD—obesity	9.98e-06	6.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—POMC—obesity	9.92e-06	6.06e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—F2—obesity	9.92e-06	6.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PRKCB—obesity	9.92e-06	6.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ALB—obesity	9.85e-06	6.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BAD—obesity	9.8e-06	5.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—obesity	9.74e-06	5.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CETP—obesity	9.7e-06	5.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS1—obesity	9.6e-06	5.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SDC1—obesity	9.59e-06	5.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—obesity	9.53e-06	5.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—AKT1—obesity	9.5e-06	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TCF7L2—obesity	9.5e-06	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CG—obesity	9.49e-06	5.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKR1C3—obesity	9.44e-06	5.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3R1—obesity	9.42e-06	5.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IRS1—obesity	9.38e-06	5.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A4—obesity	9.34e-06	5.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SCARB1—obesity	9.29e-06	5.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	9.16e-06	5.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ALB—obesity	9.05e-06	5.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GOT1—obesity	9.04e-06	5.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—POMC—obesity	9.03e-06	5.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SREBF1—obesity	9.02e-06	5.51e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—INS—obesity	8.98e-06	5.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRL—obesity	8.91e-06	5.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCL2—obesity	8.84e-06	5.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GOT2—obesity	8.77e-06	5.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CB—obesity	8.7e-06	5.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1—obesity	8.69e-06	5.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT2—obesity	8.68e-06	5.3e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	8.65e-06	5.28e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—obesity	8.62e-06	5.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FASN—obesity	8.59e-06	5.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—BCHE—obesity	8.55e-06	5.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO3—obesity	8.47e-06	5.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CD—obesity	8.34e-06	5.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SERPINE1—obesity	8.25e-06	5.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP2E1—obesity	8.25e-06	5.04e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NQO1—obesity	8.16e-06	4.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TYK2—obesity	8.03e-06	4.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—STAT3—obesity	8.03e-06	4.9e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	7.99e-06	4.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RHOA—obesity	7.96e-06	4.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AKT1—obesity	7.96e-06	4.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3R1—obesity	7.88e-06	4.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GCG—obesity	7.82e-06	4.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A4—obesity	7.82e-06	4.77e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYCS—obesity	7.72e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOB—obesity	7.67e-06	4.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—obesity	7.65e-06	4.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GGT1—obesity	7.57e-06	4.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GOT1—obesity	7.57e-06	4.62e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NCOA1—obesity	7.46e-06	4.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—obesity	7.46e-06	4.55e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TGFB1—obesity	7.44e-06	4.54e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP19A1—obesity	7.35e-06	4.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—STK11—obesity	7.35e-06	4.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—LPL—obesity	7.33e-06	4.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—FOXO1—obesity	7.27e-06	4.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CB—obesity	7.27e-06	4.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MTOR—obesity	7.27e-06	4.44e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—COMT—obesity	6.84e-06	4.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PRKCD—obesity	6.75e-06	4.12e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNB3—obesity	6.74e-06	4.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARGC1A—obesity	6.74e-06	4.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—HMOX1—obesity	6.71e-06	4.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTHFR—obesity	6.6e-06	4.03e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GNAS—obesity	6.56e-06	4.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOB—obesity	6.43e-06	3.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—obesity	6.33e-06	3.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MMP9—obesity	6.32e-06	3.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IRS2—obesity	6.28e-06	3.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AKT1—obesity	6.25e-06	3.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK8—obesity	6.15e-06	3.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOE—obesity	6.14e-06	3.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LPL—obesity	6.14e-06	3.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CAV1—obesity	6.09e-06	3.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APOA1—obesity	6.07e-06	3.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPX1—obesity	5.99e-06	3.65e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CD36—obesity	5.83e-06	3.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BAD—obesity	5.72e-06	3.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—STAT3—obesity	5.62e-06	3.43e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—IL6—obesity	5.61e-06	3.42e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—MTHFR—obesity	5.53e-06	3.37e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IRS1—obesity	5.48e-06	3.34e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARA—obesity	5.42e-06	3.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—obesity	5.3e-06	3.24e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AGT—obesity	5.25e-06	3.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—INS—obesity	5.25e-06	3.2e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—obesity	5.22e-06	3.19e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TGFB1—obesity	5.21e-06	3.18e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—AKT1—obesity	5.17e-06	3.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOE—obesity	5.14e-06	3.14e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CAV1—obesity	5.1e-06	3.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APOA1—obesity	5.08e-06	3.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT2—obesity	5.07e-06	3.1e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CD—obesity	4.87e-06	2.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.87e-06	2.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SERPINE1—obesity	4.82e-06	2.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TYK2—obesity	4.69e-06	2.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RHOA—obesity	4.65e-06	2.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CG—obesity	4.64e-06	2.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3R1—obesity	4.6e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NOS3—obesity	4.6e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPARG—obesity	4.48e-06	2.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—obesity	4.43e-06	2.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—POMC—obesity	4.42e-06	2.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—INS—obesity	4.39e-06	2.68e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AKT1—obesity	4.33e-06	2.64e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CB—obesity	4.25e-06	2.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTOR—obesity	4.25e-06	2.59e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CD—obesity	4.08e-06	2.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALB—obesity	4.03e-06	2.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL6—obesity	3.93e-06	2.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—NOS3—obesity	3.85e-06	2.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3R1—obesity	3.85e-06	2.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKT1—obesity	3.62e-06	2.21e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CB—obesity	3.56e-06	2.17e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—STAT3—obesity	3.28e-06	2e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—obesity	3.05e-06	1.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TGFB1—obesity	3.04e-06	1.86e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—obesity	2.59e-06	1.58e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—IL6—obesity	2.29e-06	1.4e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—obesity	2.17e-06	1.32e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AKT1—obesity	2.12e-06	1.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AKT1—obesity	1.77e-06	1.08e-05	CbGpPWpGaD
